Published in Health Serv Res on December 01, 2004
Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health (2006) 1.62
Association of area socioeconomic status and breast, cervical, and colorectal cancer screening: a systematic review. Cancer Epidemiol Biomarkers Prev (2009) 1.41
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
Reducing racial and ethnic disparities in colorectal cancer screening is likely to require more than access to care. Health Aff (Millwood) (2012) 0.99
Predictors of endoscopic colorectal cancer screening over time in 11 states. Cancer Causes Control (2009) 0.93
Managed care and cancer outcomes for Medicare beneficiaries with disabilities. Am J Manag Care (2008) 0.88
Laws requiring health plans to provide direct access to obstetricians and gynecologists, and use of cancer screening by women. Health Serv Res (2007) 0.86
Screening rates and characteristics of health plan members who respond to screening reminders. Prev Chronic Dis (2006) 0.84
National trends in advanced outpatient diagnostic imaging utilization: an analysis of the medical expenditure panel survey, 2000-2009. BMC Med Imaging (2013) 0.83
Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use? Cancer (2011) 0.83
Managed care market share and primary treatment for cancer. Health Serv Res (2006) 0.81
Macro-level factors impacting geographic disparities in cancer screening. Health Econ Rev (2014) 0.78
Intention to receive cancer screening in Native Americans from the Northern Plains. Cancer Causes Control (2010) 0.77
Explaining large mortality differences between adjacent counties: a cross-sectional study. BMC Public Health (2016) 0.75
Modeling the impact of Medicare Advantage payment cuts on ambulatory care sensitive and elective hospitalizations. Health Serv Res (2011) 0.75
The Association between Medicare Advantage Market Penetration and Diabetes in the United States. Front Public Health (2015) 0.75
Area-level Socioeconomic Inequalities in the Use of Mammography Screening: A Multilevel Analysis of the Health of Houston Survey. Womens Health Issues (2016) 0.75
Chronic Disease Prevalence and Medicare Advantage Market Penetration: Findings From the Medical Expenditure Panel Survey. Health Serv Res Manag Epidemiol (2015) 0.75
Mammography utilization among Black and White Medicare beneficiaries in high breast cancer mortality US counties. Cancer Causes Control (2013) 0.75
The Medical Expenditure Panel Survey: a national health information resource. Inquiry (1997) 4.92
Association of managed care market share and health expenditures for fee-for-service Medicare patients. JAMA (1999) 3.01
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin (2002) 2.94
The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med (2000) 2.40
The effect of HMOs on fee-for-service health care expenditures: evidence from Medicare. J Health Econ (1997) 2.12
Factors associated with women's adherence to mammography screening guidelines. Health Serv Res (1998) 1.87
HMO market penetration and hospital cost inflation in California. JAMA (1991) 1.80
The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care (1998) 1.71
Influence of financial productivity incentives on the use of preventive care. Am J Med (2001) 1.61
Differences in rates of cancer screening by usual source of medical care. Data from the 1987 National Health Interview Survey. Med Care (1991) 1.56
Interval adherence to mammography screening guidelines. Med Care (1991) 1.49
Managed care, technology adoption, and health care: the adoption of neonatal intensive care. Rand J Econ (2002) 1.40
Cost-sharing and the utilization of clinical preventive services. Am J Prev Med (1999) 1.37
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35
The knowledge and use of screening tests for colorectal and prostate cancer: data from the 1987 National Health Interview Survey. Prev Med (1990) 1.32
Managed care and technology adoption in health care: evidence from magnetic resonance imaging. J Health Econ (2001) 1.31
The impact of HMO penetration on the rate of hospital cost inflation, 1985-1993. Inquiry (1997) 1.30
HMO penetration and the cost of health care: market discipline or market segmentation? Am Econ Rev (1996) 1.25
Determinants of managed care penetration. J Health Econ (1998) 1.20
Decline in hospital utilization and cost inflation under managed care in California. JAMA (1996) 1.17
Type of health care coverage and the likelihood of being screened for cancer. Med Care (1998) 1.11
Managed care, consolidation among health care providers, and health care: evidence from mammography. Rand J Econ (1999) 1.09
Competition among hospitals. J Health Econ (1988) 1.09
Do HMOs make a difference? Use of health services. Inquiry (2000) 1.05
Health maintenance organization penetration and the practice location choices of new physicians: a study of large metropolitan areas in the United States. Med Care (1998) 1.05
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
Analysis of private health insurance premium growth rates: 1985-1992. Med Care (1995) 1.00
HMO growth and the geographical redistribution of generalist and specialist physicians, 1987-1997. Health Serv Res (2000) 0.98
The competitive effects of HMOs: a review of the evidence. Inquiry (1985) 0.96
A national survey of attitudes regarding participation in prostate carcinoma testing. Cancer (1996) 0.93
The NCQA's quality compass: evaluating managed care in the United States. Health Aff (Millwood) (1998) 0.87
HMO market penetration and costs of employer-sponsored health plans. Health Aff (Millwood) (2000) 0.85
Housing instability and food insecurity as barriers to health care among low-income Americans. J Gen Intern Med (2006) 3.90
Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med (2005) 3.55
Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis. Ann Intern Med (2011) 3.52
Clinical practice patterns and cost effectiveness of human epidermal growth receptor 2 testing strategies in breast cancer patients. Cancer (2009) 2.63
Body mass index, provider advice, and target gestational weight gain. Obstet Gynecol (2005) 2.38
Effect of managed care insurance on the use of preventive care for specific ethnic groups in the United States. Med Care (2002) 2.34
Variation in access to health care for different racial/ethnic groups by the racial/ethnic composition of an individual's county of residence. Med Care (2004) 2.25
Massachusetts health reform and disparities in coverage, access and health status. J Gen Intern Med (2010) 2.24
Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med (2004) 2.21
Association between language proficiency and the quality of primary care among a national sample of insured Latinos. Med Care (2007) 2.21
Secondary use of electronic health record data: spontaneous triggered adverse drug event reporting. Pharmacoepidemiol Drug Saf (2010) 2.03
Trends in colonoscopy for colorectal cancer screening. Med Care (2007) 1.89
Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med (2007) 1.87
Measuring patient preferences for colorectal cancer screening using a choice-format survey. Value Health (2007) 1.86
Comparison of prospective and retrospective indicators of the quality of end-of-life cancer care. J Clin Oncol (2008) 1.70
Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis. Circ Cardiovasc Qual Outcomes (2014) 1.65
Elucidating the role of place in health care disparities: the example of racial/ethnic residential segregation. Health Serv Res (2012) 1.55
The association of race, socioeconomic status, and health insurance status with the prevalence of overweight among children and adolescents. Am J Public Health (2003) 1.53
The impact of financial incentives on physician productivity in medical groups. Health Serv Res (2002) 1.47
Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups. Cancer Epidemiol Biomarkers Prev (2006) 1.39
Prescription drug dispensing limits and patterns. Manag Care Interface (2005) 1.38
Integrating multiple social statuses in health disparities research: the case of lung cancer. Health Serv Res (2012) 1.35
Are gatekeeper requirements associated with cancer screening utilization? Health Serv Res (2004) 1.35
Rates and predictors of colorectal cancer screening. Prev Chronic Dis (2006) 1.31
How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences? A comparison in Canada and the United States using a stated-choice survey. Health Econ (2009) 1.27
Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care (2002) 1.26
An electronic health record-based intervention to improve tobacco treatment in primary care: a cluster-randomized controlled trial. Arch Intern Med (2009) 1.26
How the new medicare drug benefit could affect vulnerable populations. Health Aff (Millwood) (2006) 1.21
Changes in health status experienced by women with gestational diabetes and pregnancy-induced hypertensive disorders. J Womens Health (Larchmt) (2005) 1.16
How does cost matter in health-care discrete-choice experiments? Health Econ (2011) 1.15
Factors affecting breast cancer risk reduction practices among California physicians. Prev Med (2004) 1.14
An experiment on simplifying conjoint analysis designs for measuring preferences. Health Econ (2003) 1.14
Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay. J Oncol Pract (2010) 1.14
Health technology assessment and private payers' coverage of personalized medicine. J Oncol Pract (2011) 1.10
Predictors of compliance with the postpartum visit among women living in healthy start project areas. Matern Child Health J (2006) 1.09
Challenges to the translation of genomic information into clinical practice and health policy: Utilization, preferences and economic value. Curr Opin Mol Ther (2008) 1.08
Correlates of prescription drug use during pregnancy. J Womens Health (Larchmt) (2005) 1.07
Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling. Genet Med (2011) 1.07
Acculturation and colorectal cancer screening among older Latino adults: differential associations by national origin. J Gen Intern Med (2009) 1.06
Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception (2010) 1.06
Comparing electronic health record portals to obtain patient-entered family health history in primary care. J Gen Intern Med (2013) 1.05
Moving beyond the typologies of managed care: the example of health plan predictors of screening mammography. Health Serv Res (2004) 1.03
Toxicokinetic modeling of persistent organic pollutant levels in blood from birth to 45 months of age in longitudinal birth cohort studies. Environ Health Perspect (2012) 1.02
A health services research agenda for cellular, molecular and genomic technologies in cancer care. Public Health Genomics (2009) 1.01
Pre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus volume in infants. Environ Health Perspect (2012) 1.01
Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res (2008) 1.00
Assessing the effects of race and ethnicity on use of complementary and alternative therapies in the USA. Ethn Health (2005) 0.99
Accuracy of race, ethnicity, and language preference in an electronic health record. J Gen Intern Med (2014) 0.98
Use of a web-based risk appraisal tool for assessing family history and lifestyle factors in primary care. J Gen Intern Med (2013) 0.98
What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings. J Gen Intern Med (2008) 0.98
Does patient cost sharing matter? Its impact on recommended versus controversial cancer screening services. Am J Manag Care (2004) 0.97
Prenatal and postnatal serum PCB concentrations and cochlear function in children at 45 months of age. Environ Health Perspect (2014) 0.97
Factors affecting participation in a breast cancer risk reduction telephone survey among women from four racial/ethnic groups. Prev Med (2005) 0.96
Use of practice-based research network data to measure neighborhood smoking prevalence. Prev Chronic Dis (2013) 0.96
Personalized medicine and oncology practice guidelines: a case study of contemporary biomarkers in colorectal cancer. J Natl Compr Canc Netw (2011) 0.95
Disparities in cancer screening in individuals with a family history of breast or colorectal cancer. Cancer (2011) 0.95
Biotechnology and Medicare's new technology policy: lessons from three case studies. Health Aff (Millwood) (2006) 0.94
Race/ethnicity, socioeconomic status and the health of pregnant women. J Health Psychol (2007) 0.93
Influence of body weight on patients' satisfaction with ambulatory care. J Gen Intern Med (2002) 0.93
Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med (2010) 0.92
Association of regional variation in primary care physicians' colorectal cancer screening recommendations with individual use of colorectal cancer screening. Prev Chronic Dis (2007) 0.92
Patient costs for medication abortion: results from a study of five clinical practices. Womens Health Issues (2006) 0.91
Is the prevalence of gatekeeping in a community associated with individual trust in medical care? Med Care (2003) 0.90
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care (2011) 0.90
Missed opportunities: family history and behavioral risk factors in breast cancer risk assessment among a multiethnic group of women. J Gen Intern Med (2007) 0.89
Association of breastfeeding with maternal depressive symptoms. J Womens Health (Larchmt) (2006) 0.89
Lifestyle behavior counseling for women patients among a sample of California physicians. J Womens Health (Larchmt) (2005) 0.89
Drug withdrawals in the United States: a systematic review of the evidence and analysis of trends. Curr Drug Saf (2007) 0.88
Hospital characteristics and racial disparities in hospital mortality from common medical conditions. J Natl Med Assoc (2007) 0.88
Variation in screening mammography and Papanicolaou smear by primary care physician specialty and gatekeeper plan (United States). Cancer Causes Control (2004) 0.88
A cohort study of developmental polychlorinated biphenyl (PCB) exposure in relation to post-vaccination antibody response at 6-months of age. Environ Res (2010) 0.88
Race and family history assessment for breast cancer. J Gen Intern Med (2005) 0.87
Looking back at 10 years of trastuzumab therapy: what is the role of HER2 testing? A systematic review of health economic analyses. Per Med (2009) 0.87
Medicare formulary coverage for top-selling biologics. Nat Biotechnol (2009) 0.87
Influence of patient preferences on the cost-effectiveness of screening for lynch syndrome. J Oncol Pract (2012) 0.87
Analysis of the toxicogenomic effects of exposure to persistent organic pollutants (POPs) in Slovakian girls: correlations between gene expression and disease risk. Environ Int (2011) 0.86
Colorectal cancer screening differential costs for younger versus older Americans. Am J Prev Med (2006) 0.86